Anna Antonell

4.2k total citations
40 papers, 1.2k citations indexed

About

Anna Antonell is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Anna Antonell has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 24 papers in Psychiatry and Mental health and 14 papers in Molecular Biology. Recurrent topics in Anna Antonell's work include Alzheimer's disease research and treatments (29 papers), Dementia and Cognitive Impairment Research (24 papers) and Functional Brain Connectivity Studies (9 papers). Anna Antonell is often cited by papers focused on Alzheimer's disease research and treatments (29 papers), Dementia and Cognitive Impairment Research (24 papers) and Functional Brain Connectivity Studies (9 papers). Anna Antonell collaborates with scholars based in Spain, United States and Sweden. Anna Antonell's co-authors include José Luís Molinuevo, Albert Lladó, Raquel Sánchez‐Valle, Beatríz Bosch, Mircea Balasa, Juan Fortea, Daniel Alcolea, Lorena Rami, Alberto Lleó and Mario Ezquerra and has published in prestigious journals such as Neurology, Annals of Neurology and International Journal of Molecular Sciences.

In The Last Decade

Anna Antonell

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Antonell Spain 19 540 449 386 231 218 40 1.2k
Britta Brix Germany 17 617 1.1× 264 0.6× 484 1.3× 268 1.2× 238 1.1× 25 1.2k
Anna Antonell Spain 19 493 0.9× 324 0.7× 317 0.8× 132 0.6× 236 1.1× 41 1.1k
Dimitrios Papadopoulos Greece 16 303 0.6× 336 0.7× 145 0.4× 178 0.8× 361 1.7× 42 1.4k
Oriol Dols‐Icardo Spain 16 700 1.3× 323 0.7× 212 0.5× 564 2.4× 335 1.5× 40 1.2k
Diego Sepúlveda‐Falla Germany 18 884 1.6× 579 1.3× 235 0.6× 189 0.8× 344 1.6× 46 1.4k
Martin Schain Sweden 19 310 0.6× 281 0.6× 179 0.5× 174 0.8× 329 1.5× 43 1.2k
Andrea Tedde Italy 24 490 0.9× 455 1.0× 157 0.4× 201 0.9× 96 0.4× 67 1.3k
Foudil Lamari France 17 415 0.8× 215 0.5× 367 1.0× 144 0.6× 136 0.6× 27 814
M. Atiya United States 6 246 0.5× 186 0.4× 329 0.9× 46 0.2× 88 0.4× 7 841
Nadia Magdalinou United Kingdom 17 840 1.6× 404 0.9× 388 1.0× 750 3.2× 490 2.2× 22 1.7k

Countries citing papers authored by Anna Antonell

Since Specialization
Citations

This map shows the geographic impact of Anna Antonell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Antonell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Antonell more than expected).

Fields of papers citing papers by Anna Antonell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Antonell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Antonell. The network helps show where Anna Antonell may publish in the future.

Co-authorship network of co-authors of Anna Antonell

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Antonell. A scholar is included among the top collaborators of Anna Antonell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Antonell. Anna Antonell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tort‐Merino, Adrià, Neus Falgàs, Sergi Borrego‐Écija, et al.. (2025). α-Synuclein Seed Amplifications Assay in a Cohort With Cognitive Impairment. Neurology. 105(7). e214040–e214040.
2.
Thirion, Bertrand, Neus Falgàs, Sergi Borrego‐Écija, et al.. (2024). Beyond group classification: Probabilistic differential diagnosis of frontotemporal dementia and Alzheimer’s disease with MRI and CSF biomarkers. Neurobiology of Aging. 144. 1–11. 2 indexed citations
3.
Ramos‐Campoy, Oscar, David Hervás, Sergi Borrego‐Écija, et al.. (2024). Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines. International Journal of Molecular Sciences. 25(10). 5445–5445.
4.
Borrego‐Écija, Sergi, Neus Falgàs, Beatríz Bosch, et al.. (2023). Cortical thickness modeling and variability in Alzheimer’s disease and frontotemporal dementia. Journal of Neurology. 271(3). 1428–1438. 3 indexed citations
5.
Borrego‐Écija, Sergi, Anna Antonell, Albert Lladó, et al.. (2023). Galectin‐3 is upregulated in frontotemporal dementia patients with subtype specificity. Alzheimer s & Dementia. 20(3). 1515–1526. 8 indexed citations
6.
Ramos‐Campoy, Oscar, Sergi Borrego‐Écija, Raquel Ruiz‐García, et al.. (2023). Diagnostic performance RT‐QuIC based detection of alpha‐synuclein seeds in a clinical cohort with cognitive impairment. Alzheimer s & Dementia. 19(S14). 1 indexed citations
7.
Forno, Gonzalo, José Contador, Neus Falgàs, et al.. (2022). The APOE4 effect: structural brain differences in Alzheimer's disease according to the age at symptom onset. European Journal of Neurology. 30(3). 597–605. 3 indexed citations
8.
Contador, José, Adrià Tort‐Merino, Mircea Balasa, et al.. (2022). Sex differences in early‐onset Alzheimer's disease. European Journal of Neurology. 29(12). 3623–3632. 11 indexed citations
9.
Contador, José, Adrià Tort‐Merino, Mircea Balasa, et al.. (2021). Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease. NeuroImage Clinical. 32. 102804–102804. 43 indexed citations
10.
Corpas, Rubén, Marta Cosín‐Tomás, Rosa Cristòfol, et al.. (2021). Microglial Hyperreactivity Evolved to Immunosuppression in the Hippocampus of a Mouse Model of Accelerated Aging and Alzheimer’s Disease Traits. Frontiers in Aging Neuroscience. 12. 622360–622360. 18 indexed citations
11.
Falgàs, Neus, Roser Sala‐Llonch, Anna Antonell, et al.. (2020). Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures. Human Brain Mapping. 41(8). 2004–2013. 25 indexed citations
12.
Falgàs, Neus, Adrià Tort‐Merino, Mircea Balasa, et al.. (2019). Clinical applicability of diagnostic biomarkers in early‐onset cognitive impairment. European Journal of Neurology. 26(8). 1098–1104. 18 indexed citations
13.
Palencia-Madrid, Leire, Raquel Sánchez‐Valle, Oriol Grau‐Rivera, et al.. (2019). A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain). Neurobiology of Aging. 84. 236.e9–236.e15. 5 indexed citations
14.
Sánchez‐Valle, Raquel, Amanda Heslegrave, Martha Foiani, et al.. (2018). Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease. Alzheimer s Research & Therapy. 10(1). 113–113. 54 indexed citations
15.
Borrego‐Écija, Sergi, Joana Morgado, Leire Palencia-Madrid, et al.. (2017). Frontotemporal Dementia Caused by the P301L Mutation in<b> </b>the<b><i> MAPT</i></b> Gene: Clinicopathological Features of 13 Cases from the Same Geographical Origin in Barcelona, Spain. Dementia and Geriatric Cognitive Disorders. 44(3-4). 213–221. 33 indexed citations
16.
Lladó, Albert, Lorena Rami, Magda Castellvı́, et al.. (2013). Neuroimaging and Biochemical Markers in the Three Variants of Primary Progressive Aphasia. Dementia and Geriatric Cognitive Disorders. 35(1-2). 106–117. 46 indexed citations
17.
Rami, Lorena, Cristina Solé‐Padullés, Juan Fortea, et al.. (2011). Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD. International Journal of Geriatric Psychiatry. 27(2). 127–134. 33 indexed citations
18.
Solé‐Padullés, Cristina, Albert Lladó, David Bartrés‐Faz, et al.. (2011). Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum. Psychiatry Research Neuroimaging. 192(3). 140–146. 17 indexed citations
19.
Fortea, Juan, Albert Lladó, Beatríz Bosch, et al.. (2011). Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with <i>PSEN1</i> Mutations. Neurodegenerative Diseases. 8(4). 202–207. 19 indexed citations
20.
Antonell, Anna, Mircea Balasa, Rafael Oliva, et al.. (2011). A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease. Neuroscience Letters. 496(1). 40–42. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026